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ick any animal cell, and chances are 
you’ll fi  nd a protein called ankyrin 
somewhere under the plasma mem-
brane. Vann Bennett fi  rst discovered ankyrin 
(1, 2) as the anchor that connects the anion 
exchanger to the spectrin-based membrane 
skeleton in erythrocytes. Ankyrin is a mem-
ber of a family of adaptors that perform 
similar roles for multiple membrane trans-
porters as well as cell adhesion molecules 
such as E-cadherin, L1 CAMs, and dystro-
glycan—which helps explain its presence in 
multiple tissues (3).
As a postdoctoral researcher, Bennett 
spent a year developing the assay he would 
later use to purify ankyrin from red blood 
cells (4). When his former graduate re-
search advisor recruited him to work at 
Burroughs Wellcome, Bennett told him it 
should take about 18 months to fi  nish puri-
fying and characterizing the protein, and 
then he wanted to move on to other proj-
ects. Instead, the study of ankyrin family 
members has taken up his entire career 
(1–6) and provided important insights into 
how plasma membrane domains are orga-
nized (3). We caught up with Bennett at his 
lab at Duke University to talk about 
ankyrin, as well as some of his other life-
long obsessions.
HISTORICAL INTEREST
When did you ﬁ  rst consider 
pursuing a career in science?
It’s hard to say. I really loved 
history when I was in high 
school, so I thought I would 
major in history in college 
and then go to medical 
school to become a doctor 
like my father. I started out 
as a history major, but I 
found that math and chemis-
try were easy, whereas I had 
to work really hard at writing my history 
essays. [Laughs] They probably weren’t 
very good! Then I had a particularly in-
spiring chemistry professor at Stanford 
named John Brauman, who actually let 
me work in his lab for a couple of years, 
and after that I switched majors to chemis-
try and biology. I made up my own major 
by combining the biology and chemistry 
programs and trimming some of the courses 
I didn’t want to take.
Did you go on to medical school as you 
had planned?
I did. When I arrived at Johns Hopkins for 
medical school, I was still thinking about 
going into medical practice, because that’s 
what I thought people did with a medical 
degree. But my fi  rst summer, I was trying 
to think of some research that interested 
me. My advisor, Dan Nathans, suggested 
I might want to work with this young fac-
ulty member, Pedro Cuatrecasas. And 
when I heard about Pedro’s work on the 
insulin receptor, I thought, “This is what I 
want to work on.” After working in his lab 
a while I realized that I wanted to get a 
PhD, so I interrupted my medical studies 
right after the basic science courses to do 
that. Then I went back to fi  nish my MD.
I think I decided to pursue a research 
career after I spent a summer on an experi-
mental oncology fl  oor and all the patients I 
was caring for had died by the end of the 
summer. I realized that every day we were 
working very hard and doing 
the best we could, but we did 
not understand the biology 
underlying these malignan-
cies. This was something 
that, as a researcher, I could 
perhaps contribute to, where-
as there were many excellent 
doctors in my medical school 
class, and if you subtracted 
me from the doctor popula-
tion, it would not make much 
difference. [Laughs]
RETAINING INTEREST
Why did you decide to do your postdoc 
in Dan Branton’s lab?
At the time I thought, extremely naively, 
that the molecular biology revolution had 
passed and that the major discoveries in this 
area had already been made. Little did I 
know what was to come! But I was very ex-
cited by membranes. At that time this was 
an emerging area, and I felt it was attackable 
by someone with training in chemistry, as 
opposed to a genetics background.
Dan’s lab worked on membrane pro-
teins in red blood cells, so it was a good fi  t 
for me. One of the proteins they were 
working on was spectrin, which was known 
to be associated with red cell membranes, 
but it wasn’t clear how. There was a belief 
at the time that perhaps spectrin didn’t 
have a protein receptor and that instead it 
just bound directly to lipids. As it turns out, 
spectrin definitely binds to lipids, but 
there’s also a critical protein component to 
the membrane linkage. I proposed to iden-
tify that protein, and, surprisingly, that’s 
actually what I eventually did. [Laughs]
That protein turned out to be ankyrin. 
It connects membrane-spanning proteins 
fl   oating in a fl   uid phospholipid bilayer 
with the spectrin skeleton on the inner 
surface of the plasma membrane, just like 
an anchor immobilizes boats fl  oating in 
water. In our initial search for the spec-
trin-binding attachment site we expected 
the protein to itself be a membrane-span-
ning protein. Instead, spectrin bound indi-
rectly to the membrane through ankryin.
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Since discovering ankyrin, Bennett has worked to understand its many 
functions at cell membranes.
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frequently 
asked after 
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ankyrin, “Is 
this just a 
red blood 
cell thing?”
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I was frequently asked after identify-
ing ankyrin, “Is this just a red blood cell 
thing?” So I went looking for it in other 
tissues, and, amazingly, I found ankyrin 
immunoreactivity in every tissue I tested. 
This protein turned out to be an opening 
into basic organization processes in many 
cells and tissues.
It turns out that ankyrin is present in the 
cells of most multicellular animals. In 
terms of evolution, we now have some idea 
of how this might have happened: we’ve 
found that membrane-spanning proteins 
interact with ankyrin through short, intrin-
sically unstructured pep-
tide segments. These un-
structured proteins are the 
most rapidly evolving part 
of our genome, and we 
think that intrinsically un-
structured peptide seg-
ments have fueled much of 
the rapid acquisition of 
vertebrate adaptations such 
as myelination. We can ac-
tually track the ability to 
bind ankyrins in proteins 
such as voltage-gated sodi-
um channels: Drosophila 
sodium channels completely lack an 
ankyrin-binding motif and so do those of 
echinoderms, but an ankyrin-binding site is 
present in its modern form in voltage-gated 
sodium channels of zebrafi  sh.
Are ankyrins important because they help 
lend physical resilience to cell membranes?
That’s likely one component. It’s a thought 
that arose from the work on red blood cells, 
where defects in these proteins lead to 
fragile membranes. In fact, in single mole-
cule studies with our collaborator Piotr 
Marszalek, we’ve actually found that an-
kyrins behave as springs. Although cells 
and tissues must deal with mechanical 
stresses, they also need mechanisms for the 
transport and retention of proteins in spe-
cialized regions of the membrane. That, I 
think, is ankyrins’ primary importance.
Spectrin and ankyrin are found at well-
organized areas—functional domains—of 
the plasma membrane. A good example of 
that would be excitable membranes; proba-
bly the best-known system 
where ankyrins and spectrin 
operate is in the axon initial 
segments in the central ner-
vous system. These are 
ankyrin-rich domains, and, if 
you knock out ankyrin in 
mice, as we and others have 
done, then the entire initial 
segment loses its properties.
INTERESTING PLACES
Where else do ankyrins 
function?
One big surprise came from 
our work on ankyrin-B knockout mice in 
the ’90s. These animals have very severely 
disturbed nervous system formation, which 
we expected. But they also have abnormal-
ities in their skeletal muscle and abnormal 
function of their neonatal cardiomyocytes. 
Later on, a postdoc of mine, Peter Mohler, 
helped to show that mutation in the an-
kyrin-B gene can cause a human cardiac 
arrhythmia called long QT syndrome. This 
mutation causes ankyrin to lose the ability 
to coordinate normal calcium dynamics.
We’ve also found that ankyrin-B muta-
tions are likely to have a role in the function 
of pancreatic  cells and appropriate regu-
lation of insulin secretion. But one of the 
biggest surprises has been that ankyrin 
mutant mice have symptoms of accelerated 
aging in multiple organ systems. Now, 
we’re not talking about extreme accelera-
tions such as progeria, but, instead, the 
appearance of age-related disorders like 
cardiac  sinus bradycardia or diabetes in 
people in their 50s and 60s instead of their 
70s and 80s. This is something we’re very 
excited about, and we’re trying to under-
stand exactly how it’s working.
It sounds as if you have your hands full 
in the lab. What about outside of it?
Well, my wife is French. She has many 
French relatives and a French addiction, so 
we visit France whenever we can. I also 
have an Arctic addiction that she doesn’t 
share: for some reason, I’m fascinated with 
being above the Arctic Circle, especially in 
the summer. My friend Peter Agre and I 
have gone on a number of canoe and camp-
ing excursions up there; we navigated the 
Seal River in Canada in 2004, which is not 
above the Arctic circle but is far enough 
north to have polar bears.
Do you have any upcoming excursions?
There’s a route called the Porcupine River 
that starts in the Yukon and goes 600 miles 
until it hits the Yukon River in the middle 
of Alaska. If I can get a group of maybe 
seven or eight people, plus guides, we 
could do this as a canoeing trip that would 
take about three weeks. Of course, it’s 
hard to get together that many people who 
can commit to a trip that long. I told my 
wife I’m willing to go alone, but appar-
ently I’m not allowed.
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Mice bearing a mutation in ankyrin B (right 
two) exhibit cardiac arrhythmia and defective 
pancreatic function.
“Spectrin and 
ankyrin are 
found at well-
organized 
areas—
functional 
domains—of 
the plasma 
membrane.”
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Bennett (in yellow) and a guide shoot some 
scary Seal River rapids.